OSCR

RFWD2 Mitigates AD-Like Cognitive Impairments via the JNK-SGK1 Signaling Pathway in Mice.

Overview

Authors: Mengjiao Ying1,2, Xiaochuan Qi1,3, Ao Wang1,3, Guangshang Zhong1,4, Wenhui Tong1,2, Danting Yu1,2, Gaofeng Liu1,2, Yu Guo1,3
  1. Anhui Provincial Center for Neural Regeneration Technology and New Medical Materials Engineering Research, Bengbu Medical University, Bengbu, Anhui, China
  2. School of Life Sciences, Bengbu Medical University, Bengbu, Anhui, China
  3. School of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui, China
  4. Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Pathology, Jinan, Shandong, China
Journal: CNS neuroscience & therapeutics, volume 32, issue 4, article e70860
Dates: received 8 February 2025; accepted 10 March 2026; published online 9 April 2026; in print April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/cns.70860 · PMID 41954517 · PMCID PMC13064414 · OpenAlex W7152464638
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: mouse (organism), rat (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Alzheimer disease, cognitive function, JNK pathway, RFWD2, SGK1
MeSH: Alzheimer Disease*, Cognitive Dysfunction*, Immediate-Early Proteins*, MAP Kinase Signaling System*, Protein Serine-Threonine Kinases*, Ubiquitin-Protein Ligases*, Animals, Hippocampus, Male, Mice, Mice, Inbred C57BL, Neurons, PC12 Cells, Rats, Serum-Glucocorticoid Regulated Kinases, Signal Transduction (* major topic)
Topic: Alzheimer's disease research and treatments (Physiology, Medicine), according to OpenAlex
Funding: Science Research Project of Bengbu Medical University (2021byfy002); Undergraduate Innovative Training Program of China (202410367024); National Natural Science Foundation of China (82371382, 81771381); Natural Science Foundation of Anhui Province (2308085MH256); Postgraduate Innovative Training Program of Bengbu Medical University (Byycx23007)
Citations: cited by 1 paper (Europe PMC); 41 references in the paper

Abstract

Background: Alzheimer disease (AD) is a degenerative disorder of the central nervous system. Its main pathological feature is the formation of neurofibrillary tangles through abnormal β‐amyloid protein (Aβ) aggregation and excessive Tau protein phosphorylation. Ring finger and WD repeating domain 2 (RFWD2) is an E3 ubiquitin ligase that regulates neuronal dendrite complexity through the c‐Jun N‐terminal kinase (JNK) pathway. This study aimed to investigate the regulatory effect of RFWD2 on the downstream protein, serum/glucocorticoid‐regulated kinase 1 (SGK1), through the JNK pathway and explore its influence on AD pathogenesis.

Methods: Cognitive‐level behavioral detection was performed in RFWD2+/− mice. Cultured PC12 cells and cortical neurons were also used to analyze the changes in signaling pathways caused by the decreased expression of RFWD2 in vitro and correlations between the expression of related proteins and key signaling pathways of AD at the molecular level.

Results: Decreased RFWD2 expression led to cognitive deficits in AD mice, resulting in mitochondrial swelling, fragmentation of hippocampal neurons, abnormally high reactive oxygen species levels, and an imbalance between antiapoptotic and proapoptotic proteins. This effect was significantly improved by inhibiting the JNK pathway and SGK1 protein expression. Furthermore, in vitro experiments showed that in PC12 cells and cortical neurons downregulated by RFWD2, the expression levels of p‐JNK, SGK1, and p‐Tau increased, and those of LC3B/Beclin‐1 decreased; ROS levels increased, and apoptosis was induced; inhibiting JNK or SGK1 expression reversed these changes.

Conclusion: RFWD2 regulates SGK1 expression through the JNK pathway, thereby regulating mitochondrial autophagy and apoptosis, altering the expression levels of p‐Tau and Aβ proteins, inducing AD‐like symptoms in mice, and promoting AD development. The RFWD2–JNK–SGK1 axis provides a valuable basis for studying the mechanisms of AD occurrence and developing early intervention strategies.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The datasets generated and/or analysed during the current study are not publicly available due personal privacy protection but are available from the corresponding author on reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 16 MeSH terms, 5 funders, 41 references.

Cite

This paper

Ying, M., Qi, X., Wang, A., Zhong, G., Tong, W., Yu, D., Liu, G., & Guo, Y. (2026). RFWD2 Mitigates AD-Like Cognitive Impairments via the JNK-SGK1 Signaling Pathway in Mice. CNS neuroscience & therapeutics, 32(4), e70860. https://doi.org/10.1002/cns.70860

BibTeX

@article{ying2026rfwd2,
author = {Ying, Mengjiao and Qi, Xiaochuan and Wang, Ao and Zhong, Guangshang and Tong, Wenhui and Yu, Danting and Liu, Gaofeng and Guo, Yu},
title = {{RFWD2 Mitigates AD-Like Cognitive Impairments via the JNK-SGK1 Signaling Pathway in Mice}},
journal = {CNS neuroscience \& therapeutics},
year = {2026},
month = apr,
volume = {32},
number = {4},
pages = {e70860},
publisher = {Wiley},
issn = {1755-5930},
doi = {10.1002/cns.70860},
url = {https://doi.org/10.1002/cns.70860},
pmid = {41954517},
pmcid = {PMC13064414}
}

RIS

TY - JOUR
AU - Ying, Mengjiao
AU - Qi, Xiaochuan
AU - Wang, Ao
AU - Zhong, Guangshang
AU - Tong, Wenhui
AU - Yu, Danting
AU - Liu, Gaofeng
AU - Guo, Yu
TI - RFWD2 Mitigates AD-Like Cognitive Impairments via the JNK-SGK1 Signaling Pathway in Mice
T2 - CNS neuroscience & therapeutics
J2 - CNS Neurosci Ther
PY - 2026
DA - 2026/04/01
VL - 32
IS - 4
SP - e70860
SN - 1755-5930
PB - Wiley
DO - 10.1002/cns.70860
UR - https://doi.org/10.1002/cns.70860
LA - en
ER -

CSL-JSON

{
"id": "10.1002/cns.70860",
"type": "article-journal",
"title": "RFWD2 Mitigates AD-Like Cognitive Impairments via the JNK-SGK1 Signaling Pathway in Mice",
"container-title": "CNS neuroscience & therapeutics",
"author": [
{
"family": "Ying",
"given": "Mengjiao"
},
{
"family": "Qi",
"given": "Xiaochuan"
},
{
"family": "Wang",
"given": "Ao"
},
{
"family": "Zhong",
"given": "Guangshang"
},
{
"family": "Tong",
"given": "Wenhui"
},
{
"family": "Yu",
"given": "Danting"
},
{
"family": "Liu",
"given": "Gaofeng"
},
{
"family": "Guo",
"given": "Yu"
}
],
"container-title-short": "CNS Neurosci Ther",
"volume": "32",
"issue": "4",
"page": "e70860",
"DOI": "10.1002/cns.70860",
"PMID": "41954517",
"PMCID": "PMC13064414",
"ISSN": "1755-5930",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/cns.70860",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s10571-026-01749-z
Nyap1 Redirects JNK Signaling to Couple Neuroprotection with Circuit Regeneration After Spinal Cord Injury.
Journal: Cellular and molecular neurobiology
In common: cellular / molecular, 2 references
[2] doi:10.1111/acel.70622
High Intrinsic Aerobic Capacity Is Associated With a Distinct Epigenetic and Signaling Profile in the Aged Rat Brain.
Journal: Aging cell
In common: rat, cellular / molecular, 1 reference
[3] doi:10.1111/acel.70616
Transcriptomic Evidence of Mitochondrial Double-Stranded RNA Accumulation in Brain Aging and Alzheimer's Disease.
Journal: Aging cell
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[4] doi:10.1016/j.nbd.2026.107379 [code]
DYRK1A and Parkinson's disease, facts and hypotheses.
Journal: Neurobiology of disease
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[5] doi:10.3389/fpsyt.2026.1828806
Integrative multi-omics and machine learning analysis identifies candidate biomarkers associated with mitochondrial quality control in major depressive disorder.
Journal: Frontiers in psychiatry
In common: rat, 1 reference
[6] doi:10.3389/fnmol.2026.1844602
Prenatal and neonatal housing conditions affect anxiety-like behavior in adulthood in rats and interact with brain-derived neurotrophic factor (BDNF) Val66Met to alter expression of BDNF and stress markers in the ventral hippocampus.
Journal: Frontiers in molecular neuroscience
In common: rat, 1 reference
[7] doi:10.1038/s41467-026-71112-9 [code]
Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[8] doi:10.1002/exp2.70160
<i>RBFOX1</i> Dysfunction Unlocks <i>APOE4</i>-Associated Microglial Genesis and Exacerbates Alzheimer's Pathology in Human Cerebral Organoids.
Journal: Exploration (Beijing, China)
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[9] doi:10.1038/s44321-026-00473-x
OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation.
Journal: EMBO molecular medicine
In common: mouse, cellular / molecular, 1 reference
[10] doi:10.1186/s12974-026-03844-w
SGK1 inhibition supports neuroprotection in spinal cord injury by suppressing oxidative stress and AIM2 activation via FoxO1 mediated mitophagy.
Journal: Journal of neuroinflammation
In common: mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.